Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02242058 · ClinicalTrials.gov registry record
QST-Pupillometry in Sickle Cell Disease Patients
A clinical trial, sponsored by Julia Finkel.
- Completed
- Registry status
- 96
- Enrollment target
NCT02242058: Completed study, sponsored by Julia Finkel.
NCT02242058 is a clinical trial that has completed, run by Julia Finkel. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02242058 has completed, sponsored by Julia Finkel.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
There has been little progress for effective treatment of pain in sickle cell disease (SCD) patients. Many organizations have recognized that understanding the causes and reducing the burden of pain in SCD is critical in order to improve the quality of life in SCD patients. As patients with SCD face the challenge of living with both acute and chronic pain which is often improperly treated, our translational and interdisciplinary project aims to identify objective measures of pain sensitivity and its biochemical and genetic correlates. We hypothesize that SCD patients will have decreased tolerance to thermal and electrical stimuli.
Primary Outcome
Using a TSA (thermal sensory analyzer), the patients hot and cold perception and tolerance will be measured in the outpatient groups (high-pain and low-pain frequency and controls).
Interventions
- OTHER Quantitative sensory testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2013-08 |
| Est. Completion | 2018-11 |
What the finished NCT02242058 record still lists
NCT02242058 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quantitative sensory testing is the first listed.
NCT02242058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02242058 about?
NCT02242058 is a clinical study titled "QST-Pupillometry in Sickle Cell Disease Patients". There has been little progress for effective treatment of pain in sickle cell disease (SCD) patients. Many organizations have recognized that understanding the causes and reducing the burden of pain in SCD is critical in order to improve the quality of life in SCD patients. As patients with SCD face...
What is the current status of trial NCT02242058?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2013-08. Estimated completion is 2018-11.
What interventions are being tested in trial NCT02242058?
The interventions under investigation include: Quantitative sensory testing (OTHER).
Who is sponsoring clinical trial NCT02242058?
This trial is sponsored by Julia Finkel, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia